These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17484716)

  • 21. Kidney failure due to methoxyflurane.
    Mazzia VD
    Leg Med; 1982; ():59-71. PubMed ID: 7121187
    [No Abstract]   [Full Text] [Related]  

  • 22. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 23. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 24. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 25. Safe use of acetaminophen.
    Barton KN
    CMAJ; 2003 May; 168(11):1390. PubMed ID: 12771057
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug information sources.
    Cardoni AA
    Nursing; 1978 May; 8(5):56-60. PubMed ID: 247229
    [No Abstract]   [Full Text] [Related]  

  • 27. Patient interpretation of label instructions.
    Holt GA; Dorcheus L; Hall EL; Beck D; Ellis E; Hough J
    Am Pharm; 1992 Mar; NS32(3):58-62. PubMed ID: 1561967
    [No Abstract]   [Full Text] [Related]  

  • 28. Sources of prescribing information.
    Dipalma JR
    Am Fam Physician; 1978 Oct; 18(4):188-91. PubMed ID: 707269
    [No Abstract]   [Full Text] [Related]  

  • 29. [More information on drug package inserts and counseling replace the warning triangle].
    Beermann B; Liliemark J; Johansson K
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1918, 1921. PubMed ID: 16044776
    [No Abstract]   [Full Text] [Related]  

  • 30. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug counterfeiting burden remains a guess, experts say.
    Traynor K
    Am J Health Syst Pharm; 2009 Jul; 66(14):1246-8. PubMed ID: 19574593
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA gets advice on Modernization Act compliance.
    Marwick C
    JAMA; 1998 Oct; 280(14):1214-5. PubMed ID: 9786361
    [No Abstract]   [Full Text] [Related]  

  • 33. APhA2009 House of Delegates: serving the association and the profession.
    Weitzel KW; Tisdale JE; Mattingly J
    J Am Pharm Assoc (2003); 2009; 49(4):474-80. PubMed ID: 19589755
    [No Abstract]   [Full Text] [Related]  

  • 34. The off-label use of medication in South Africa--what about some information for medical practitioners?
    Jansen RM
    S Afr Med J; 2009 Jun; 99(6):438-9. PubMed ID: 19736843
    [No Abstract]   [Full Text] [Related]  

  • 35. Dosing information for paediatric patients: are they really "therapeutic orphans"?
    Caswell AJ
    Med J Aust; 2003 Nov; 179(10):560. PubMed ID: 14609429
    [No Abstract]   [Full Text] [Related]  

  • 36. Establishing a drug product identification directory.
    Vuurens R; Mitala JJ
    Hosp Pharm; 1978 Mar; 13(3):141-2. PubMed ID: 10306926
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical desktop references.
    LaPorta MA
    Ann Intern Med; 1994 May; 120(9):813-4. PubMed ID: 8147562
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug information sources.
    J Kans Med Soc; 1968 Dec; 69(12):597-8. PubMed ID: 5703411
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug information sources for the R.N.
    Torrence JK
    Imprint; 1978 Feb; 25(1):22, 55-6. PubMed ID: 245333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.